Clicky

XI-S+ Stretched
clear pixel

BRINGING NEW PERSPECTIVES

TO SOFT TISSUE REPAIR

clear pixel
clear pixel
clear pixel
clear pixel

Events

clear pixel
clear pixel

American College of Surgeons Clinical Congress 2017

Colorado Therapeutics will present and exhibit at the American College of Surgeons (ACS) 103rd annual Clinical Congress held from October 22-26, 2017 at the San Diego Convention Center, in San Diego, California. Learn more at https://www.facs.org/clincon2017.

clear pixel
+ Event Archives
clear pixel

News

clear pixel
clear pixel
15 May

Colorado Therapeutics Appoints Medtronic Executive John Lorbiecki as Chief Operating Officer in Advance of XI-S+™ Launch

BROOMFIELD, Colo. – May 15, 2017 – Colorado Therapeutics LLC, a commercial-stage medical device company with a proprietary technology platform for the production of innovative cross-linked tissue products, announced that John Lorbiecki has been appointed to the newly created position of chief operating officer effective March 21, 2017. Mr. Lorbiecki brings broad leadership experience from… Read more »

28 Oct

Colorado Therapeutics and Micro Interventional Devices Enter into a License Agreement for Use of the PolyCor™ Anchoring Technology

BROOMFIELD, Colo. – October 28, 2016 – Colorado Therapeutics LLC, a privately held medical device company with a proprietary technology platform for the production of innovative cross-linked tissue products, announced today that it has entered into a worldwide exclusive license agreement with Micro Interventional Devices, Inc. (MID), a leader in minimally invasive and catheter-based compliant… Read more »

21 Oct

Colorado Therapeutics Receives 510(k) Clearance for a Novel Xenograft Implant for Soft Tissue Repairs

– Series A Financing will be Opened to Support Commercial Launch – BROOMFIELD, CO – October 21, 2016 – Colorado Therapeutics LLC, a privately held medical device company with a proprietary technology platform for the production of innovative cross-linked tissue products, announced today that it has received 510(k) clearance from the U.S. Food and Drug… Read more »

28 Jan

Colorado Therapeutics Submits 510(k) for a Novel Xenograft Implant for Soft Tissue Repairs

– Colorado Therapeutics Closes Angel Financing Round and Will Open Series A Financing in Support of Anticipated Commercial Launch – BROOMFIELD, CO – January 28, 2016 – Colorado Therapeutics LLC, a privately held medical device company that is leveraging over 15 years of innovative and proprietary cross-linked tissue processing technology, announced today that it has… Read more »

clear pixel
+ News Archives
+ View Our Technology